2.18
price up icon1.40%   0.03
after-market Handel nachbörslich: 2.18
loading

Ventyx Biosciences Inc Aktie (VTYX) Neueste Nachrichten

pulisher
03:30 AM

Vanguard Group Inc's Strategic Acquisition in Ventyx Biosciences Inc - GuruFocus.com

03:30 AM
pulisher
Nov 04, 2024

Ventyx Biosciences: Ready To Escape "The Crash Cycle" (NASDAQ:VTYX) - Seeking Alpha

Nov 04, 2024
pulisher
Oct 28, 2024

These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts - Markets Insider

Oct 28, 2024
pulisher
Oct 28, 2024

Brokerages Set Ventyx Biosciences, Inc. (NASDAQ:VTYX) PT at $8.29 - MarketBeat

Oct 28, 2024
pulisher
Oct 17, 2024

HC Wainwright Cuts Earnings Estimates for Ventyx Biosciences - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Ventyx Biosciences maintains Neutral rating from H.C. Wainwright - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 in Ulcerative Colitis at UEG Week 2024 - Marketscreener.com

Oct 16, 2024
pulisher
Oct 16, 2024

Ventyx Biosciences maintains Neutral rating from H.C. Wainwright By Investing.com - Investing.com UK

Oct 16, 2024
pulisher
Oct 16, 2024

Ventyx Biosciences Presents New 52-Week Results from the - GlobeNewswire

Oct 16, 2024
pulisher
Oct 15, 2024

Ventyx Biosciences (NASDAQ:VTYX) Given "Neutral" Rating at HC Wainwright - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Ventyx reports positive Phase 2 ulcerative colitis trial data - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Ventyx reports positive Phase 2 ulcerative colitis trial data By Investing.com - Investing.com Canada

Oct 15, 2024
pulisher
Oct 15, 2024

VTYX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Oct 15, 2024
pulisher
Oct 15, 2024

Ventyx Biosciences Inc (VTYX) stock analysis: A comprehensive overview - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024 - The Manila Times

Oct 15, 2024
pulisher
Oct 08, 2024

Did Ventyx Biosciences Inc (VTYX) perform well in the last session? - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

An analyst sees good growth prospects for Ventyx Biosciences Inc (VTYX) - SETE News

Oct 07, 2024
pulisher
Oct 07, 2024

Sanofi Invests $27M in Ventyx Bio - San Diego Business Journal

Oct 07, 2024
pulisher
Oct 03, 2024

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Ventyx Biosciences Inc (VTYX) may enjoy gains as insiders got busy in the recent days - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Is Ventyx Biosciences Inc (VTYX) a good investment opportunity? - US Post News

Oct 02, 2024
pulisher
Sep 30, 2024

Gaining Ground: Ventyx Biosciences Inc (VTYX) Closes Lower at 2.31, Down -2.12 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Take off with Ventyx Biosciences Inc (VTYX): Get ready for trading - SETE News

Sep 30, 2024
pulisher
Sep 28, 2024

VTYX Stock Rises on Strategic Equity Investment Deal With SNY - MSN

Sep 28, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Buys 2,287,570 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Stock Surge: Ventyx Biosciences Inc (VTYX) Closes at 2.39, Marking a -2.85 Increase/Decrease - The Dwinnex

Sep 26, 2024
pulisher
Sep 26, 2024

Ventyx Biosciences, Inc. (NASDAQ:VTYX) to Post FY2024 Earnings of ($2.13) Per Share, HC Wainwright Forecasts - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Sanofi’s $27 Million Investment in Ventyx Biosciences - Global Legal Chronicle

Sep 25, 2024
pulisher
Sep 25, 2024

Adversity is less terrifying than hope: Ventyx Biosciences Inc (VTYX) - SETE News

Sep 25, 2024
pulisher
Sep 24, 2024

Ventyx Biosciences retains stock target, neutral rating despite Sanofi's $27M stake - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Benjamin F. Edwards & Company Inc. Buys 16,858 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Ventyx gets $27 million investment from Sanofi - The Pharma Letter

Sep 24, 2024
pulisher
Sep 23, 2024

Ventyx deal a sign of Sanofi’s growing interest neuro-immunology? - BioCentury

Sep 23, 2024
pulisher
Sep 23, 2024

Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m deal - Pharmaceutical Technology

Sep 23, 2024
pulisher
Sep 23, 2024

Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences - MSN

Sep 23, 2024
pulisher
Sep 23, 2024

Ventyx Biosciences Inc (VTYX) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Ventyx Biosciences (NASDAQ:VTYX) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Ventyx stock climbs 8% on $27M Sanofi investment - MSN

Sep 23, 2024
pulisher
Sep 23, 2024

Thoughtworks (NASDAQ:TWKS) Sees Large Volume Increase - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

VTYX’s Q2 earnings predictions: What the experts say - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Sanofi investment in Ventyx shows VTX3232 interest, says H.C. Wainwright - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M - Fierce Biotech

Sep 23, 2024
pulisher
Sep 23, 2024

Victory Capital (NASDAQ:VCTR) Hits New 12-Month High at $56.29 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Ventyx stock climbs 8% on $27M Sanofi investment (NASDAQ:VTYX) - Seeking Alpha

Sep 23, 2024
pulisher
Sep 23, 2024

Sanofi invests $27 million in Ventyx Biosciences By Investing.com - Investing.com India

Sep 23, 2024
pulisher
Sep 23, 2024

Ventyx Biosciences Shares Rise Premarket on Sanofi Investment - Marketscreener.com

Sep 23, 2024
pulisher
Sep 23, 2024

Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi - GlobeNewswire

Sep 23, 2024
pulisher
Sep 22, 2024

(TWST) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Sep 22, 2024
pulisher
Sep 22, 2024

How the (TVE) price action is used to our Advantage - Stock Traders Daily

Sep 22, 2024
pulisher
Sep 21, 2024

Seven Eight Capital LP Buys Shares of 22,269 Victory Capital Holdings, Inc. (NASDAQ:VCTR) - MarketBeat

Sep 21, 2024
pulisher
Sep 20, 2024

Ventyx Biosciences Repeat Insider Selling Not A Positive Indicator - Simply Wall St

Sep 20, 2024
pulisher
Sep 19, 2024

JT Extends Vector Tender - Tobacco Reporter

Sep 19, 2024
pulisher
Sep 18, 2024

Taking a Closer Look At Ventyx Biosciences Inc (VTYX) Following Its Recent Trade - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Ventyx Biosciences Inc (VTYX) looking to reclaim success with recent performance - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Acadian Asset Management LLC Makes New Investment in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - MarketBeat

Sep 18, 2024
pulisher
Sep 17, 2024

VTYX overperforms with a 2.18 increase in share price - US Post News

Sep 17, 2024
pulisher
Sep 16, 2024

Market Momentum Report: Ventyx Biosciences Inc (VTYX)’s Positive Close at 2.29 - The Dwinnex

Sep 16, 2024
pulisher
Sep 13, 2024

VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ventyx Biosciences, Inc. - AccessWire

Sep 13, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):